1.
|
Details
of PDMR/person closely associated with them ('PCA')
|
||
a)
|
Name
|
Mr L
Debruyne
|
|
b)
|
Position/status
|
President,
Global Vaccines
|
|
c)
|
Initial
notification/
amendment
|
Initial
Notification
|
|
2.
|
Details
of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
|
||
a)
|
Name
|
GlaxoSmithKline
plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details
of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transaction(s) has been
conducted
|
||
a)
|
Description
of the financial instrument
|
Ordinary
shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
|
b)
|
Nature
of the transaction
|
The
sale of 20,000 Ordinary Shares on 2 June 2017 at a price of
£17.0177
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
£17.0177
|
20,000
|
||
|
|
||
d)
|
Aggregated
information
|
n/a
(single transaction)
|
|
Aggregated
volume Price
|
|
||
e)
|
Date of
the transaction
|
2017-06-02
|
|
f)
|
Place
of the transaction
|
London
Stock Exchange (XLON)
|
1.
|
Details
of PDMR/person closely associated with them ('PCA')
|
||
a)
|
Name
|
Mr I W
Whyte
|
|
b)
|
Position/status
|
PCA of
Mrs V A Whyte (SVP & Company Secretary)
|
|
c)
|
Initial
notification/
amendment
|
Initial
Notification
|
|
2.
|
Details
of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
|
||
a)
|
Name
|
GlaxoSmithKline
plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details
of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transaction(s) has been
conducted
|
||
a)
|
Description
of the financial instrument
|
Ordinary
shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
|
b)
|
Nature
of the transaction
|
Transfer
of 1,310 Ordinary Shares to spouse for nil
consideration.
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
£0.00
|
1,310
|
||
|
|
||
d)
|
Aggregated
information
|
n/a
(single transaction)
|
|
Aggregated
volume Price
|
|
||
e)
|
Date of
the transaction
|
2017-06-02
|
|
f)
|
Place
of the transaction
|
n/a
|
1.
|
Details
of PDMR/person closely associated with them ('PCA')
|
||
a)
|
Name
|
Mrs V A
Whyte
|
|
b)
|
Position/status
|
SVP
& Company Secretary
|
|
c)
|
Initial
notification/
amendment
|
Initial
Notification
|
|
2.
|
Details
of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
|
||
a)
|
Name
|
GlaxoSmithKline
plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details
of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transaction(s) has been
conducted
|
||
a)
|
Description
of the financial instrument
|
Ordinary
shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
|
b)
|
Nature
of the transaction
|
The
receipt of 1,310 Ordinary Shares from spouse for nil
consideration.
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
£0.00
|
1,310
|
||
|
|
||
d)
|
Aggregated
information
|
n/a
(single transaction)
|
|
Aggregated
volume Price
|
|
||
e)
|
Date of
the transaction
|
2017-06-02
|
|
f)
|
Place
of the transaction
|
n/a
|
1.
|
Details
of PDMR/person closely associated with them ('PCA')
|
||
a)
|
Name
|
Mrs V A
Whyte
|
|
b)
|
Position/status
|
SVP
& Company Secretary
|
|
c)
|
Initial
notification/
amendment
|
Initial
Notification
|
|
2.
|
Details
of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
|
||
a)
|
Name
|
GlaxoSmithKline
plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details
of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transaction(s) has been
conducted
|
||
a)
|
Description
of the financial instrument
|
Ordinary
shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
|
b)
|
Nature
of the transaction
|
The
sale of 9,215 Ordinary Shares on 2 June 2017 at a price of
£17.07.
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
£17.07
|
9,215
|
||
|
|
||
d)
|
Aggregated
information
|
n/a
(single transaction)
|
|
Aggregated
volume Price
|
|
||
e)
|
Date of
the transaction
|
2017-06-02
|
|
f)
|
Place
of the transaction
|
London
Stock Exchange (XLON)
|
1.
|
Details
of PDMR/person closely associated with them ('PCA')
|
||
a)
|
Name
|
Mr I W
Whyte
|
|
b)
|
Position/status
|
PCA of
Mrs V A Whyte (SVP & Company Secretary)
|
|
c)
|
Initial
notification/
amendment
|
Initial
Notification
|
|
2.
|
Details
of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
|
||
a)
|
Name
|
GlaxoSmithKline
plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details
of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transaction(s) has been
conducted
|
||
a)
|
Description
of the financial instrument
|
Ordinary
shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
|
b)
|
Nature
of the transaction
|
The
sale of 4,690 Ordinary Shares 2 June 2017 at a price of
£17.07.
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
£17.07
|
4,690
|
||
|
|
||
d)
|
Aggregated
information
|
n/a
(single transaction)
|
|
Aggregated
volume Price
|
|
||
e)
|
Date of
the transaction
|
2017-06-02
|
|
f)
|
Place
of the transaction
|
London
Stock Exchange (XLON)
|
|
GlaxoSmithKline plc
|
|
(Registrant)
|
|
|
Date: June
05, 2017
|
|
|
|
|
By: VICTORIA
WHYTE--------------------------
|
|
|
|
Victoria Whyte
|
|
Authorised
Signatory for and on
|
|
behalf
of GlaxoSmithKline plc
|